Page last updated: 2024-08-26

hydroperoxyisophosphamide and Colonic Neoplasms

hydroperoxyisophosphamide has been researched along with Colonic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flentje, M; Latz, D; Manegold, C; Schraube, P; Schulze, T; Weber, KJ1
Latz, D; Weber, KJ1

Other Studies

2 other study(ies) available for hydroperoxyisophosphamide and Colonic Neoplasms

ArticleYear
Combined effects of ionizing radiation and 4-hydroperoxyfosfamide in vitro.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1998, Volume: 46, Issue:3

    Topics: Animals; Carcinoma, Squamous Cell; Cell Cycle; Cell Survival; Colonic Neoplasms; Combined Modality Therapy; Cricetinae; Cricetulus; Female; Humans; Ifosfamide; In Vitro Techniques; Lung; Melanoma; Radiation Dosage; Radiation Tolerance; Radiation, Ionizing; Survival Analysis; Tumor Cells, Cultured; Uterine Cervical Neoplasms

1998
Transient DNA double-strand breakage in 4-hydroperoxyifosfamide-treated mammalian cells in vitro does not interact with the rejoining of radiation-induced double-strand breaks.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2002, Volume: 178, Issue:5

    Topics: Animals; Cell Survival; Colonic Neoplasms; Cricetinae; Cricetulus; DNA; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Humans; Ifosfamide; Radiation Dosage; Tumor Cells, Cultured

2002